Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
about
Radiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosisOptimal Selection of Radiotherapy as Part of a Multimodal Approach for Hepatocellular CarcinomaA concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular CarcinomaIncorporating GSA-SPECT into CT-based dose-volume histograms for advanced hepatocellular carcinoma radiotherapyApplication of radiotherapy for hepatocellular carcinoma in current clinical practice guidelines2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaSignificance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinomaComparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma.Helical tomotherapy for single and multiple liver tumoursPhase I dose-escalation study of proton beam therapy for inoperable hepatocellular carcinomaThe role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus.Radiation-associated liver injury.Radiation-Induced Liver Injury in Three-Dimensional Conformal Radiation Therapy (3D-CRT) for Postoperative or Locoregional Recurrent Gastric Cancer: Risk Factors and Dose Limitations.Feasibility and efficacy of helical tomotherapy in cirrhotic patients with unresectable hepatocellular carcinoma.The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care.RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.Outcomes and Predictors of Toxicity after Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres for Unresectable Hepatocellular Carcinoma.Hepatic dysfunction after radiotherapy for primary gastric lymphoma.Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma.Reducing the probability of radiation-induced hepatic toxicity by changing the treatment modality from helical tomotherapy to fixed-beam intensity-modulated radiotherapyDosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma.Hypofractionated radiotheapy using helical tomotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinomaA dose-volume intercomparison of volumetric-modulated arc therapy, 3D static conformal, and rotational conformal techniques for portal vein tumor thrombus in hepatocellular carcinomaPredictive models for regional hepatic function based on 99mTc-IDA SPECT and local radiation dose for physiologic adaptive radiation therapySuperiority of helical tomotherapy on liver sparing and dose escalation in hepatocellular carcinoma: a comparison study of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy.Consensus for Radiotherapy in Hepatocellular Carcinoma from The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): Current Practice and Future Clinical Trials.Identification of Biologically Effective Dose-Volumetric Parameters That Predict Radiation-Induced Hepatic Toxicity in Patients Treated With Helical Tomotherapy for Unresectable Locally Advanced Hepatocellular Carcinoma.Options for radiotherapy in the treatment of liver metastases.A comparison of liver protection among 3-D conformal radiotherapy, intensity-modulated radiotherapy and RapidArc for hepatocellular carcinoma.The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma.Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma.Long-term pathological and immunohistochemical features in the liver after intraoperative whole-liver irradiation in rats.Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area.The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma.Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma.Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.Assessing the role of volumetric-modulated arc therapy in hepatocellular carcinoma.
P2860
Q26738533-412A21AA-1ADB-4C8D-A38F-40EA0A65CC7AQ26744097-CC717B1A-043B-4515-ADED-B967D8DFEC31Q26752478-A694BCB1-3DEE-4D83-89A0-A0ACFF7C1474Q26797643-58D6A8A9-6D06-4509-A404-AFC7F2D3FB3DQ27030865-D369CC14-B446-4788-9D9D-C9A9CB87E662Q28076314-1805FB2C-E135-4036-8965-2F55F60C3943Q28392783-1850EDD3-E2C6-4A94-9903-A69F0E70D482Q28394414-8CB778C4-24E4-4674-A755-43C3E2B7A297Q33593108-78524732-303D-40A6-95C4-D4585B15EB0FQ33894890-80FE7EA7-6E80-45BF-B1DE-3321960C6339Q33975859-A9ADE452-39E6-4CFF-87BC-C80DF5D1BEC6Q34977179-071EE45D-72C7-4EF4-A280-9AC4821985FAQ35234037-45167E7C-1B75-4D8F-8633-1BFC5ACF8B91Q35297759-E74852CA-102D-4DA8-A56C-AAD1E26490DBQ35751290-FE9873D2-6D03-40AE-9F3F-353983C6B6C8Q35765404-635BD014-D7C9-4AD1-A254-9265565F5472Q35833182-27A57EE0-E24A-493F-8357-48EA477F6D60Q36326035-3395E511-46D6-4002-A012-19DEF539285BQ36396455-B1314C4C-F1AF-4963-8233-B3170AD5BC20Q36499990-AB1886AC-4D77-42A8-840F-655D7DA23448Q36537059-973CC025-6CD7-4E7E-A3EE-F85F73CEAA32Q36545343-4E31B82E-EB27-4C50-8D19-3047EF69D0C4Q36555907-1AB8361E-E219-46C3-BAD4-A850B1FA5EDBQ36604392-7DFA82EB-4715-46EA-89A5-29DC88025BF3Q36811589-2A3F7646-94CA-4744-B732-C8D1DCD1D1CBQ37006939-DF41AE7A-165B-4D7A-811A-C29FB900826DQ37009671-5C54BB76-EC0A-4BF9-A7A2-98E2CC533CCFQ37055687-CA0D31FD-9161-4C83-BD43-7E1628AE6528Q37124697-0220787E-038F-4FF2-AE62-256C5F7D11DEQ37176354-91B486E5-F616-481D-98B9-12C9D5165B1DQ37305042-9DDE6569-0B3A-4D85-817D-BF3EB6AD5347Q37580324-5DA84C62-95A4-4461-A3C6-A1F1A2B8768AQ37641843-6F7E84BE-263E-4D6D-9B2E-704E48FD3751Q38282463-5870DD92-1535-4C02-A40B-4B3FE02B6884Q39245337-D0EE7306-7712-4140-B66D-DAAFE8CB93F2Q42249970-254B7430-6FA0-4157-AC69-97178B85D542Q43865857-C5763B12-E3F4-4C6A-84AC-6A777DF18486Q43897398-66337542-0022-44FE-8029-4367BCEAA0AAQ44238324-199A9644-B823-49E4-9647-C67C1E66DCFAQ46017793-333526ED-6576-4383-9CCE-272706A1C548
P2860
Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Dose-volumetric parameters pre ...... sional conformal radiotherapy.
@en
Dose-volumetric parameters pre ...... sional conformal radiotherapy.
@nl
type
label
Dose-volumetric parameters pre ...... sional conformal radiotherapy.
@en
Dose-volumetric parameters pre ...... sional conformal radiotherapy.
@nl
prefLabel
Dose-volumetric parameters pre ...... sional conformal radiotherapy.
@en
Dose-volumetric parameters pre ...... sional conformal radiotherapy.
@nl
P2093
P921
P1476
Dose-volumetric parameters pre ...... sional conformal radiotherapy.
@en
P2093
Chang-Min Kim
Dae Yong Kim
Eun Kyung Hong
Hyun Beom Kim
Joong-Won Park
Sang Jae Park
Seong Hoon Kim
Woo Jin Lee
P304
P356
10.1016/J.IJROBP.2006.08.015
P407
P577
2006-10-23T00:00:00Z